Page last updated: 2024-10-25

ciprofloxacin and Lupus Erythematosus, Cutaneous

ciprofloxacin has been researched along with Lupus Erythematosus, Cutaneous in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Lupus Erythematosus, Cutaneous: A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Newman, AJ1
Mullens, D1
Lin, CC1
Barr, J1

Other Studies

1 other study available for ciprofloxacin and Lupus Erythematosus, Cutaneous

ArticleYear
Subacute cutaneous lupus erythematosus observed with ciprofloxacin.
    BMJ case reports, 2018, Dec-22, Volume: 11, Issue:1

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Lupus Erythematosus, Cutaneous; Male; Middle Aged; Pro

2018